Guidance on Contingency Planning for People who use Drugs and COVID-19: Version 2.0


13 May 2020 by Scottish Drugs Forum
This Scottish Drugs Forum-produced guidance is aimed at those planning and designing services as well as those managing and delivering services for people who use drugs, in particular those people on opioid substitution therapy (OST) and people who inject drugs. The guidance includes a section on blood borne virus (BBV) testing, noting that "all delayed BBV results from dry blood spot tests must be proactively followed up in a timely manner once COVID-19 related restrictions allow".